- Home
- RSSS vs TLSA Comparison
RSSS vs TLSA Comparison
Compare RSSS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- TLSA
- Stock Information
- Founded
- RSSS 2006
- TLSA 2013
- Country
- RSSS United States
- TLSA United Kingdom
- Employees
- RSSS N/A
- TLSA N/A
- Industry
- RSSS Business Services
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- TLSA Health Care
- Exchange
- RSSS Nasdaq
- TLSA Nasdaq
- Market Cap
- RSSS 90.6M
- TLSA 187.0M
- IPO Year
- RSSS N/A
- TLSA 2000
- Fundamental
- Price
- RSSS $3.37
- TLSA $1.70
- Analyst Decision
- RSSS
- TLSA
- Analyst Count
- RSSS 0
- TLSA 0
- Target Price
- RSSS N/A
- TLSA N/A
- AVG Volume (30 Days)
- RSSS 62.9K
- TLSA 342.3K
- Earning Date
- RSSS 11-13-2025
- TLSA 05-06-2025
- Dividend Yield
- RSSS N/A
- TLSA N/A
- EPS Growth
- RSSS N/A
- TLSA N/A
- EPS
- RSSS N/A
- TLSA N/A
- Revenue
- RSSS $48,753,578.00
- TLSA N/A
- Revenue This Year
- RSSS $12.13
- TLSA N/A
- Revenue Next Year
- RSSS $6.34
- TLSA N/A
- P/E Ratio
- RSSS N/A
- TLSA N/A
- Revenue Growth
- RSSS 14.85
- TLSA N/A
- 52 Week Low
- RSSS $2.32
- TLSA $0.63
- 52 Week High
- RSSS $4.24
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- RSSS 68.42
- TLSA 44.63
- Support Level
- RSSS $2.96
- TLSA $1.51
- Resistance Level
- RSSS $3.39
- TLSA $1.88
- Average True Range (ATR)
- RSSS 0.13
- TLSA 0.16
- MACD
- RSSS 0.01
- TLSA -0.01
- Stochastic Oscillator
- RSSS 95.35
- TLSA 38.78
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.